World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
22810
World Ranking
16709
National Ranking
551

Gilles Vassal publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gilles Vassal sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 524 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gilles Vassal D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gilles Vassal sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gilles Vassal is affiliated with the Institut Gustave Roussy in France, contributing extensively to the fields of medicine, biochemistry, genetics, and molecular biology. Their research spans multiple subfields including pediatrics, perinatology and child health, oncology, molecular biology, pulmonary and respiratory medicine, and neurology.

The scientist's work frequently addresses key topics such as childhood cancer survivors' quality of life, neuroblastoma research and treatments, pharmaceutical studies and practices, lung cancer treatments and mutations, cancer genomics and diagnostics, CAR-T cell therapy research, and cancer therapeutics and mechanisms.

Vassal has published numerous papers in notable journals. Recent publications include:

  • "Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children," 2020, New England Journal of Medicine
  • "Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAFV600E non-small cell lung cancer," 2020, European Journal of Cancer
  • "Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma," 2020, European Journal of Cancer
  • "Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients," 2021, Neuro-Oncology Advances
  • "ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients," 2020, European Journal of Cancer

Frequent publication venues where Vassal's work appears include:

  • European Journal of Cancer
  • Journal of Clinical Oncology
  • Cancer Research
  • The Lancet Oncology
  • Neuro-Oncology

Scientific collaboration is a significant aspect of Vassal's career. Frequent co-authors include Birgit Geoerger, Andrew D.J. Pearson, Lynley V. Marshall, Karsten Nysom, and Teresa de Rojas, with whom they have worked on numerous projects.

Vassal's research contributes to understanding and developing treatments for pediatric cancers, as well as exploring resistance mechanisms in lung cancer and innovative diagnostic techniques. Their body of work also covers advancing checkpoint inhibitor therapies for pediatric patients and highlights multiple clinical and translational research efforts focused on improving therapeutic strategies and outcomes in oncology and related medical fields.

Best Publications

  • The landscape of genomic alterations across childhood cancers

    Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter

  • High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: Results of the MOSCATO 01 trial

    Christophe Massard;Stefan Michiels;Charles Ferté;Marie-Cécile Le Deley

  • Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

    Vijay Ramaswamy;Marc Remke;Eric Bouffet;Simon Bailey

  • Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

    Fabrice Andre;Bastien Job;Philippe Dessen;Philippe Dessen;Attila Tordai

  • Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

    Ruth Ladenstein;Ruth Ladenstein;Ulrike Pötschger;Andrew D J Pearson;Penelope Brock

  • Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients.

    M. Schlumberger;F. De Vathaire;J. P. Travagli;G. Vassal

  • Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting.

    Irène Brigger;Jackie Morizet;Geneviève Aubert;Hélène Chacun

  • Metabolism of Irinotecan (CPT-11) by CYP3A4 and CYP3A5 in Humans

    Alexandre Santos;Sylvie Zanetta;Thierry Cresteil;Alain Deroussent

  • Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma

    E. Baudin;G. Pellegriti;M. Bonnay;A. Penfornis

  • Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

    Véronique Minard-Colin;Anne Aupérin;Marta Pillon;G.A. Amos Burke

  • Risk of Secondary Leukemia After a Solid Tumor in Childhood According to the Dose of Epipodophyllotoxins and Anthracyclines: A Case-Control Study by the Société Française d’Oncologie Pédiatrique

    Marie-Cécile Le Deley;Thierry Leblanc;Akthar Shamsaldin;Marie-Anne Raquin

  • Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas.

    Stephanie Puget;Cathy Philippe;Dorine A. Bax;Bastien Job

  • Potential of the Conditionally Replicative Adenovirus Ad5-Δ24RGD in the Treatment of Malignant Gliomas and Its Enhanced Effect with Radiotherapy

    Martine L.M. Lamfers;Jacques Grill;Clemens M.F. Dirven;Victor W. Van Beusechem

  • Dose-dependent Neurotoxicity of High-Dose Busulfan in Children: A Clinical and Pharmacological Study

    Gilles Vassal;Alain Deroussent;Olivier Hartmann;Dominique Challine

  • A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study

    Alberto S. Pappo;Gilles Vassal;John J. Crowley;Vanessa Bolejack

  • Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood.

    Axelle Menu-Branthomme;Carole Rubino;Akhtar Shamsaldin;Michael M. Hawkins

  • Population Pharmacokinetics and Pharmacogenetics of Imatinib in Children and Adults

    Aurélie Petain;Darouna Kattygnarath;Julie Azard;Etienne Chatelut

  • Pharmacokinetic-pharmacodynamic relationships of imatinib and its main metabolite in patients with advanced gastrointestinal stromal tumors.

    Catherine Delbaldo;Etienne Chatelut;Micheline Ré;Alain Deroussent

  • MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase–Mediated HOX/Stem Cell Gene Signature

    Nathalie Gaspar;Lynley Marshall;Lara Perryman;Dorine A. Bax

  • Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children.

    V Méresse;O Hartmann;G Vassal;E Benhamou

Frequent Co-Authors

Jacques Grill
Jacques Grill Institut Gustave Roussy
Andrew D.J. Pearson
Andrew D.J. Pearson Royal Marsden NHS Foundation Trust
François Doz
François Doz Université Paris Cité
Fabrice Andre
Fabrice Andre Institut Gustave Roussy
Jean-Charles Soria
Jean-Charles Soria Amgen (United States)
Chris Jones
Chris Jones Institute of Cancer Research
Stefan Michiels
Stefan Michiels University of Paris-Saclay
Laurence Brugières
Laurence Brugières Institut Gustave Roussy
Thierry de Baere
Thierry de Baere Institut Gustave Roussy
Kathy Pritchard-Jones
Kathy Pritchard-Jones University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you consider studying Medicine in the USA, it’s important to explore related online degrees and alternate career pathways in healthcare. These programs offer the flexibility to study remotely and can help you enter or advance in the rapidly evolving health sector.

For those interested in leadership or management roles, pursuing a healthcare administration accelerated degree can open doors to higher-level positions in hospitals and healthcare organizations. If you’re already a registered nurse, you might consider bridging your qualifications with adn to np bridge programs—these make it easier to become a nurse practitioner and expand your scope of practice.

Nutrition and food science are also in high demand. An accredited and flexible option is the best online food science degree, which prepares graduates for careers in health education, dietetics, and research. Alternatively, professionals interested in hospital administration can look into the cahme accredited online mha programs list for master’s-level degrees that meet industry standards.

Each of these paths offers unique opportunities and can complement or enhance your medical education journey.

Best Scientists Citing Gilles Vassal

Trending Scientists

Recently Published Articles